European Stocks Higher On U.S. Vaccine Approval, Extended Brexit Talks

European stocks traded higher on Monday, despite mixed Asian cues, following news that the United States will start Covid-19 vaccinations today after the drug regulators approved the Pfizer- BioNTech's COVID-19 vaccine. The U.S. Centers for Disease Control and Prevention or CDC, gave the approval for Pfizer- BioNTech's COVID-19 vaccine, following the Emergency Use Authorization or EUA.